Paul Boutros, PhD, MBA
Dr. Paul Boutros pursued his undergraduate education at the University of Waterloo in Chemistry. During the co-op portion of his degree he worked for a wide range of organizations, including the Federal Government, a water-purification company and Petro-Canada. But he found his true calling during a work-term spent at Michigan State University developing computer models of how cells respond to drugs and toxins. Dr. Boutros’ undergraduate thesis extended this work to focus on modeling DNA damage, and was awarded First Place in the National Undergraduate Chemistry Conference. In 2004, Paul started his PhD at the Ontario Cancer Institute, in Toronto. During his studies he received several awards, including the CIHR/Next Generation First Prize and the Invitrogen Canada Young Investigator Silver Award. After publishing 27 peer-reviewed papers over four years, Paul was awarded his PhD in 2008 for his development of novel biomarkers for predicting cancer severity.
In 2008, Paul started his independent research career at the Ontario Institute for Cancer Research, as Principal Investigator in Informatics and Biocomputing, and Assistant Professor in the Departments of Pharmacology and Toxicology and Medical Biophysics at the University of Toronto. He is a Prostate Cancer Canada Rising Star in Prostate Cancer Research, a Terry Fox New Investigator Award recipient, a University of Waterloo Young Alumni Award winner and recipient of the Early Career Graduate Student Teaching Award. In 2016, he received his MBA from the University of Toronto, and in 2018, Paul was awarded the Dorval Prize by the Canadian Cancer Society, recognizing the best early career investigator nationally.
In 2018, Paul relocated to the University of California, Los Angeles, taking on leadership roles at the Jonsson Comprehensive Cancer Centre and the Institute for Precision Health. As a Professor in the Departments of Human Genetics and Urology, Paul’s research focuses on personalizing therapy for cancer by developing novel statistical methodologies. He leads the ICGC-TCGA DREAM Somatic Mutation Calling Challenge that is setting global standards for analyzing cancer genomic data, and drives programs in cancer genomics, data science and biomarker translation.
Director Cancer Data Science, Jonsson Comprehensive Cancer Centre, University of California, Los Angeles
Associate Director Cancer Informatics, Institute for Precision Health, University of California
Professor, Departments of Human Genetics and Urology, University of California, Los Angeles
Pete Bridge, PhD
Pete is currently a senior lecturer in Radiotherapy at the University of Liverpool where he teaches radiotherapy planning, physics and research skills. Prior to this, he worked as a senior lecturer and undergraduate course coordinator at Queensland University of Technology in Brisbane, Australia. Pete’s research interests lie in innovative radiotherapy education and particularly the use of simulation. He conducted the first evaluation of a virtual linear accelerator educational resource prior to its commercialisation as VERT (Virtual Environment for Radiotherapy Training) and led a funded project to develop and evaluate a medical imaging 3D immersive educational environment. He has published on a wide range of educational innovations ranging from VR applications to engaging patients to provide student feedback. He co-authored the “CT Anatomy for Radiotherapy” textbook and currently delivers training on MR Anatomy for Radiotherapy. Pete’s PhD concerned the use of 3D immersive visualisation for radiotherapy structure outlining and he has just completed supervision of another project investigating use of 3D VR for IGRT image fusion. Despite this he maintains that he is not a geek. In his spare time he enjoys mountains, mud and good beer.
Sophie Foxcroft BSc., MRT(T), MHSc., CHE
Sophie Foxcroft is the Director of System and Infrastructure Planning at Cancer Care Ontario where she leads strategic system planning and capacity planning to ensure a sustainable health system. Sophie’s key responsibilities include: development of the Ontario Cancer Plan; oversight of capital investment strategies; infrastructure planning for diagnostic and treatment facilities; health human resource workforce planning for oncology specialists; and service volume planning for complex malignant hematology, cancer imaging, radiation treatment and palliative care. Prior to joining CCO, Sophie was Director of Operations for the Radiation Medicine Program at Princess Margaret Cancer Centre, UHN where she had responsibility for ensuring the delivery of safe, high quality radiation therapy to over 8,000 patients per year and implementing multi-million dollar infrastructure and capital investments to improve care for patients. She was the inaugural CCO Clinical Quality Lead, Radiation Treatment Program, and co-lead on a province-wide radiation oncology peer review audit that resulted in established provincial guidelines and identified key metrics and success indicators to evaluate peer review practice. Sophie trained as a radiation therapist at the Princess Margaret Hospital School of Radiation Therapy, holds a MHSc in Health Administration from the University of Toronto and is a Certified Health Executive with the Canadian College of Health Leaders.
Charles Washington, MBA, RT(T), ARRT, FASRT
Charles serves as the Senior Director in Radiation Oncology at Memorial Sloan-Kettering Cancer Center in New York, NY serving in this role since 2012. Prior to his transition to New York, Charles served as Director of Proton Therapy, Clinical Director of Operations, Radiation Therapy Program Director, and Certified Radiation Therapist at The University of Texas M.D. Anderson Cancer Center in Houston, TX for 25 years.
Charles started his therapy career after graduation from Wayne State University’s Radiation Therapy Technology Program in Detroit, Michigan, with a baccalaureate degree in science. He received his Masters in Business Administration from the Keller Graduate School of Management of DeVry University. Charles is currently matriculating in the Doctoral Program in Organizational Change and Leadership at the University of Southern California. Charles’ dissertation is an explanatory sequential mixed methodology review of service recovery impact on patient experience and satisfaction in radiation oncology.
Charles has also served as an American Society of Radiologic Technologist appointed Trustee of the American Registry of Radiologic Technologists, having completed eight years of service on that board, and as well, an ARRT appointed Board Trustee of the American Board of Imaging Informatics, serving for over four years.
Charles has edited and authored many professional articles and books, inclusive of the Principles and Practice of Radiation Therapy textbook published by Mosby, currently developing a fifth edition. Charles has instructed and lectured on the local, regional, national, and international levels.